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In the past five years, science-based food-safety issues have been a staple of
daily news in the United States as well as in other parts of the world. Develop-
ing news on mad cow and foot-and-mouth diseases from Europe, furor over
golden rice in Southeast Asia, and the continuing coverage of the risks and
benefits of agricultural biotechnology have vigorously put science and the
scientist in the public arena. As the lenses of the public are trained increasingly
on science and the scientist, it becomes inevitable, then, for the scientist to
also have the public very much in mind.
In the evolving interaction involving the public, the mass media, and
scientists, it is reasonable to expect some convergence in the discourse on
biotechnology. However, what we have witnessed so far seems to show
increasing divergence. Although public-opinion studies in the United States
do not exhibit the anti-biotechnology phenomenon that we hear about, the
movement against biotechnology has certainly gained momentum in other parts
of the world. This is particularly true in Europe and parts of Asia, where public
opinion about biotechnology has been unfavorable and public suspicions of
GMOs and institutional regulatory agencies and industry have remained
unabated.
Indeed, we would not be here today if it were not for the intriguing question
as to why agricultural biotechnology has become a lightning rod for conflicting
public discourses. Although I am not a scientist and can comment only from
within the limits of my training and scholarly reflections, I would like to proffer
some insights that relate to the communication dimension of this phenomenon.
In reexamining the divergent opinions expressed in public discourses over
biotechnology, I thought it best to go back to the basic question: Who are the
actors and from what contextual frames do they see agricultural biotechnology
as they further their agendas in the public sphere?
Clearly the actors involved are scientists, the mass media, and involved
publics. It also is obvious that each of these actors brings to the discourse a
way of knowing and presenting truth and knowledge, a peculiar rhetorical and
epistemological style, and a set of values and meanings that cannot be removed
from history and immediate experiences. Whether or not they are, in our view,
protagonists or antagonists in the biotech debate would also depend on the
frame that we ourselves use in examining the unfolding events of agricultural
biotechnology.
THE SCIENTIFIC FRAME AND THE TRANSFORMATION OF
SCIENTIFIC DISCOURSE
In order to understand the manner of scientific discourse or talk, a look back in
history might help. As we all know, the Scientific Revolution was characterized
by a denunciation of scholasticism and the use of rhetoric in investigating
nature. In order to dissociate itself from the moralizing and personalizing types
of discourse, science had to seek other ways of presenting information. The
imperative to have a distinctive discourse for science was particularly
underscored in Thomas Sprat’s History of the Royal Society, which admonished
its members to separate the knowledge of Nature from the colors of rhetoric,
the devices of fancy, or the delightful deceit of fables. Robert Hooke, in his draft
preamble to the original statutes of the Royal Society of London, specifically
argued that scientists should have nothing to do with “Rhetoric.” During a
scientific congress in Italy in 1839, Grand Duke Leopold II even remarked that
one of the forbidden topics would be “eloquence.” These admonitions reflected
the need to have a scientific discourse that was characterized by logic and
analysis, the direct evidence of the phenomena, the results of observations,
stripped of all charms of fancy. In this context, scientists were conduits through
which nature spoke directly, across the great divide between the independent,
outer world of phenomena and the subjective, inner world of the observer
(Gross, 1990; Fahnestock, 1998).
These distinctive marks of scientific discourse continue to be evident in
contemporary science. Then, as now, the imperative has always been for a close,
clinical, naked, natural way of speaking, almost mathematical plainness. It
reflects both the values and social structure of science, which is entrenched in
the tradition of peer review and careful evaluation and scrutiny (Martin and
Veel, 1998; Priest, 1999). It implies a degree of separation between science and
society, with the former as the fountainhead of all new empirical knowledge.
The autonomy of science was seldom contested. Knowledge, per se, is devoid
of ethical content or moral value. It is the society, at large, that deems as good
or bad (or both) the uses of knowledge and understanding, and even pure
information, depending on the social, historical, and cultural contexts, and on
the prevailing human and social values of the times (Brown, 1998).
Thus, when modern scientists communicate, we note cautious attempts to
establish the validity of the observations they report, emphasis on methodology,
and importance given to tables, figures, photographs, and all other representa-
tions that can solidify the claim for the physical evidence generated. It is a type
of discourse that can be characterized as “forensic” or “empiricist” in that it is
largely based from observable characteristics of the natural world, aided by
actuarial, toxicological, epidemiological, or probabilistic risk analyses and risk
assessment. Using this rhetorical style, scientists simply restate the results of
scientific research and suggest that risk can be calculated with precision. To
deviate from this process is to negate the epistemological underpinnings and
moorings of the scientific enterprise. When scientists communicate with their
peers through papers, reports, or conferences, they reaffirm this built-in ethos
of empiricism and try to hold back from any celebratory discussion of the
significance or relevance of the work. The audience is left to infer and spell out
the relevance of the study for a particular context (Sera and Shea, 1991; Priest,
1999).
But what happens when scientists shift to another type of discourse? The
problem, I believe, begins when the scientific discourse slides from the forensic
or empiricist style to what I would call the “celebratory” style. Communicating
scientific reports and findings in ways that would make sense to the larger, non-
scientific (lay) audience requires that the scientific information be adjusted to
meet the lay audience’s already held values and assumptions. This celebratory
scientific discourse veers towards explicating the value and significance of
scientific discoveries for lay audiences. It focuses on the breakthroughs,
advances, contributions, applications, and benefits of scientific discoveries. It
tries to contextualize science. The increasing importance of “context” shifts the
discourse of science from the more traditional, established scientific search for
truth to the more pragmatic discourse of “science that works.” Indeed, there is
a change from a discourse of methods and processes to a discourse that gives a
final answer (Fahnestock, 1999).
In the case of agricultural biotechnology, celebratory scientific discourses
may extrapolate, for example, the social benefits of biotechnology in terms of
It can be argued that, in the era of three-second sound
bytes and diminishing attention span of media audiences,
such creative catch-phrases that herald scientific accom-
plishments and potential social benefits may just be the
proper counterpoint to other equally mind-grabbing sound
bytes such as “frankenfood” and “terminator genes.”
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solving world hunger and even poverty in developing countries. The term
“golden rice” for the genetically modified rice grain that contains beta-carotene
is an example of a celebratory connotation for science. One scientific
organization is even more effusive by referring to the so-called “golden rice” as
the “grain of hope.” It can be argued that, in the era of three-second sound
bytes and diminishing attention span of media audiences, such creative catch-
phrases that herald scientific accomplishments and potential social benefits
may just be the proper counterpoint to other equally mind-grabbing sound
bytes such as “frankenfood” and “terminator genes.” Perhaps, scientists should
fight fire with fire. While this strategy may be convenient, what the public gets
at the end of the day, however, is simply a clash of sound bytes and more
confusion.
Ironically, in an effort to make scientific discoveries relevant and appealing to
the lay audience, celebratory scientific discourse all but foregoes some of the
exacting standards of empiricism that have gained respect for science and
entrenched its institutional role in society. Thus, it has been noted that
celebratory scientific discourses tend to pay less attention to caveats, contradic-
tory evidence, and qualifications that are highlighted in forensic or empiricist
discourses. By downplaying scientific uncertainty, it alludes to greater certainty
of scientific results for public consumption (Brown, 1998).
However, as it inevitably moves closer towards the arena of debate over what
constitutes the common good and what is socially beneficial, it opens itself up
also to a wide range of questions engendered by a different set of frames of
public discourse for which science may not have the answer.
THE LAY AUDIENCE’S FRAME: MORAL AND SOCIETAL MEANINGS AND
THE DEMANDS FOR CERTAINTY
In my opinion, the lay audience’s contention over biotechnology is neither
about the science per se nor the content of forensic-empiricist discourses on
biotechnology. For how then can we explain continuing public expectations for
definitive answers or their needs for certainty, from science, even if these are
rather unrealistic demands? These expectations could only suggest that, in the
eyes of the public, science is still a repository of answers to many of the
problems that beset the human condition. I would like to offer an analogy,
despite its obvious limitation. This relationship between scientists and the
public is almost akin to the principle of the separation between church and
state. The church is respected as a purveyor of profound reflections on matters
of morality, ethics, and conscience. The public expects that. But it is altogether
a different discourse if the church dictates to the state as to what is moral and
ethical. It weakens the state.
Hence, in the public discourse of biotechnology, conflict arises when science
begins to be perceived as precluding public judgments and playing a decisive
role in setting directions, policies, and regulations on food production and
food-safety standards. There is evidence that negative public reaction to
agricultural biotechnology is driven to some extent by uneasiness over
regulatory and risk-management policies that are solely based on technical risk
analyses and risk assessment. This process is seen as disenfranchising other
discourses that embody particular values and meanings vis-à-vis biotechnology.
In the eyes of the public, it weakens the democratic nature of the public sphere
that is supposed to engage a wide spectrum of participants and discourses. The
conflict may very well be about the process of envisioning the common good
and the best way to attain it (Gilbert and Mulkay, 1984; Webber, 1990; Gregory
and Miller, 1998).
Scientific assertions evidently have a rightful niche in the public sphere.
Celebratory scientific discourses on the wonders and socio-economic benefits
of biotechnology have, in fact, been used as a rhetorical tool in several
marketing or public information campaigns. In a functioning public sphere,
however, these scientific claims must be evaluated side by side with other
assertions, each carrying a frame of meanings, priorities, and values. This may
be the reason why we do not see a blanket rejection of biotechnology. There is,
in fact, disparity in public choices and levels of support for biotechnology.
Public-opinion surveys indicate more support for the use of biotechnology for
medical or pharmaceutical purposes than for the use of biotechnology in the
production of food.
What, then, are these frames of meanings and values that inform non-
scientific or lay discourses of biotechnology? These frames pertain to (a) ethics
and morality, (b) control, (c) fairness, (d) familiarity, and (e) trust in institu-
tions that regulate biotechnology. These frames are essentially reflective of
Professor Peter Sandman’s categorization of the more than twenty factors that
influence public perceptions and opinions about risk-related issues. Using some
of these categories, let me outline the typical arguments that characterize lay
discourses of biotechnology (Juanillo, 2001).
Ethics and Morality Lay discourses tend to liberally equate “ethics” with
“moral concerns.” Hence, if the application of a technology and related
instances is unethical, it is also consequently considered morally wrong.
Public support for a technology is largely contingent on its perceived moral
acceptability. Studies indicate that moral acceptability is a strong predictor of
support for biotechnology and that moral concerns outweigh questions of risk
and utility. The emphasis on ethics has even swayed institutional structures. In
France, forums on ethics in biotechnology have been institutionalized with the
creation of National Consultative Ethics Committee (de Cheveigné et al.,
1999).
In general, lay discourses about the ethics and morality of biotechnology are
informed by naturalistic or ecocentric worldviews, which see humans as only a
part of nature. They manifest deeply held existential ideas about humankind
and our relationship with nature. Fundamental to the ethical-moral question of
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biotechnology is the guiding principle among many that nature is pure, and “all
that is natural is valuable and good in itself.” Thus, an action is right “when it
tends to preserve the integrity, stability, and beauty of the biotic community
(and) … wrong when it tends otherwise (MacLean, 1995). Hence, biotechnol-
ogy is intrinsically wrong because it is seen as tampering with nature and as
contrary to the very essence of humanity and its position in nature.
This particular discourse on biotechnology becomes even more complex
when framed in a religious perspective. “Playing God” has been a familiar
accusation against biotechnology and a basis for not a few impassioned public
objections.
Interestingly, however, nationwide surveys conducted in Austria, the United
Kingdom, Australia, Germany, Japan, and the Netherlands generally show less
ethical opposition to genetic engineering for medical, pharmaceutical, or
therapeutic applications than to applications in food production and agricul-
ture. Genetic testing and medicines are deemed useful, morally acceptable, and
to be encouraged, but genetic manipulation of food crops and animals is
considered morally unacceptable.
Control Perceived loss of control over the effects of biotechnology on human
health and the environment has been a recurring theme. For example,
biotechnology opponents cite the threat to the independence of small farmers
and the consumers’ right to know and choose. People ask how broad public
interests can be served in light of the growing concentration of ownership of
food resources in a handful of multinational companies, particularly their
control over key aspects of food growth, production, and marketing. There are
concerns over the move toward agricultural research being predominantly
influenced and funded by the very companies that stand to benefit most from
genetically modified crop technology.
There is widespread perception that the genetic engineering industry seeks to
industrialize agriculture even further and to intensify farmers’ dependence
upon industrial inputs abetted by a system of intellectual property rights, which
legally inhibits the rights of farmers to reproduce, share, and replant seeds
(Altieri, 1999).
Opponents also express fears about similar effects of agricultural biotech-
nology in developing countries, opening up the debate once more on the
dependency that technology creates on the research and manufacturing
capacities of developed economies. They believe that agricultural biotech-
nology will exacerbate the marginalization of small and resource-poor farmers
since the technology is under corporate control, protected by patents,
expensive, and inappropriate to the needs and circumstances of indigenous
people. There is a perceived threat of total “corporatization” of farming, of
unfairly burdening the farmers of developing countries who would become
dependent on corporate genetically engineered seeds, despite being unable to
afford them (Altieri, 1999).
Fairness Public debates over genetically modified foods have also centered on
the technology’s role in exacerbating social inequities. Concerned groups both
in developed and in developing societies, for example, see current intellectual
property rights as devices for perpetuating, rather than alleviating, entrenched
discrepancies between rich and poor countries (Jasanoff, 1999).
Non-government organizations also have decried the limited flow of
information and resulting lack of transparency as a result of the patent system
in developed countries. Existing patent systems allow biotechnology industries
to protect the product as well as the process, and therefore to limit the flow of
technical information. Procedures and policies have yet to be established in
order to promote access to these technologies. As a consequence, the public
perceives that the whole biotechnology business is shrouded in secrecy,
conjuring up images of technology as an instrument of social control.
Stringent regulations in developed countries on the release of genetically
modified organisms or their products also are seen as making developing
countries particularly vulnerable to uncontained on-site applications of
biotechnology as these countries do not yet have the necessary regulatory
policies. Current guidelines governing the release of genetically modified
organisms do not include provisions governing the testing and application of
organisms in other countries, particularly in the developing world. This
situation provides opportunity for the biotechnology industry to test new
products or locate their production facilities in developing countries that are ill-
prepared to respond due to the lack of national safety policies, effective
regulatory mechanisms, technical know-how, and institutional accountability.
The perception that developing countries are being “exploited” by companies
who profit from the use of indigenous biological resources has triggered anti-
biopiracy awareness campaigns by non-government organizations worldwide.
There are serious concerns that these companies are being granted patents for
products and technologies that make use of these indigenous genetic materials,
plants, and other biological resources (Altieri, 1999).
Voluntariness An exposure to risk that is perceived as involuntary is regarded
as more threatening than when an individual has a choice over personal
exposure (Frewer et al., 1997). Consumer food choices are informed by the
general feeling of well-being and satisfaction associated with products that have
been chosen voluntarily, guided in part by an array of cultural, ethnic, and
religious motivations.
The negative attitude of consumers towards biotechnology products appears
to emanate from the perception that food and dietary risks are personal choices
and ought not to be imposed on them by corporations. Much of the opposition
revolves around upholding the consumer’s autonomy and right to be informed
through mandatory labeling and disclosure of any salient nutritional differences
or new production methods in foods. In the United States, public-opinion
surveys continue to demonstrate that consumers want labeling. A Gallup poll
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conducted in September, 1999, showed that even though a bare majority of
Americans believe that biotech foods are safe, most are willing to pay more
to have labels that distinguish between gene-altered food and conventional
produce. Sixty-eight percent of the respondents said they would pay more for
labeled foods whereas 29% would not.
Moreover, as a reaction to this perceived threat, Europe and a growing
number of developing countries have proposed a Biosafety Protocol that would
require exporters of “living modified organisms” to notify the importing nation
in advance, giving that nation a chance to reject the shipment. Agricultural
commodities would be included because they contain seeds that can be
presumably planted or can escape into the environment.
Familiarity and Tradition Agriculture has been closely associated with
land-based farming where small communities have cultivated crops and
domesticated animals for consumption and commerce. In the United States,
powerful images of agriculture and the virtues of harmonious agrarian life
persist even as the modern farm has lost much of its folk character. The village
and the countryside are still perceived as the stronghold of primal American
values: a sense of human values, neighborliness, respect for family, moral
stewardship of the land, and a bastion of democracy and religion.
Opposition to the application of biotechnology in food production and
agriculture emanates partly from the belief that it destabilizes the firmly rooted
cultural archetypes and the deep symbolism associated with agrarian culture.
Many environmental and sustainable agriculture groups view transgenic food as
a symbol of the assault on traditional sources of food. Decreasing familiarity
with their food and its origin and composition engenders such anxiety. The
benefits of using biotechnology on food and crops seem far-fetched and
superfluous, bear no immediate impact on individual well-being, and lack
personal relevance.
Trust and Credibility Central to the public discourse on the risks and benefits
of biotechnology is the issue of trust and perceived credibility of societal
institutions such as regulatory agencies, life-science companies, and private
research organizations. Communication between the public and proponents of
biotechnology breaks down, perhaps irreparably, when the public perceives that
the proponents are not telling the truth about the risks of biotechnology or are
not sufficiently prepared to handle the potential risks of the technology. Public
expectations about the competence of societal institutions involved in
biotechnology are often based on the institutional track record or on the basis
of how these institutions have handled food-related crises in the past.
The level of public trust in institutions and sources of information and how
the public perceives risk work in tandem. This ongoing public suspicion of self-
interest mars the relationship between the public and the governmental
regulatory agencies and private food companies in debates over the risks and
benefits of biotechnology. As public trust in institutions declines, the public
perceives the hazards of biotechnology to be greater, and public trust in
advocacy groups increases.
The Eurobarometer surveys conducted by the European Commission in 1996
on public perceptions of biotechnology show that public authorities, adminis-
trative institutions, and industry are least trusted to tell the truth about
biotechnology, and are perceived to be least reliable to regulate biotechnology.
Non-government entities such as consumer organizations and environmental
groups are most widely trusted, followed by school- and university-based
experts. Trust, however, is issue-specific. Those in the medical profession, for
example, are most widely trusted for introducing genes into animals to produce
organs for human transplants. There also is more trust in the providers of
biotechnologies for medicinal or therapeutic use than in those involved in
biotechnologies for food production (Durant et al., 1998).
A study I conducted in Southeast Asia (the Philippines, Singapore, and
Thailand) on public perceptions of food safety manifests similar trends.
Results of the survey show that life-science and food companies and govern-
ment regulatory agencies rank lowest as trusted sources of information on
food-related risks including biotechnology. University scientists rank first in
all three countries, followed closely by non-government organizations such
as consumer-advocacy and environmental groups and the mass media. Life-
science and food companies and government regulatory agencies are perceived
as being most biased in releasing information and most likely to withhold
information on food-related risks. Moreover, the public perceives university
scientists to be much more concerned about public health and safety with
regard to biotechnology issues than are government agencies or life-science
and food companies.
THE MASS MEDIA DISCOURSE: FOCUSING ON THE FRAMES THAT SELL
Turning now to the mediator of scientific and lay discourses on biotechnology,
I believe that there is no doubt about the critical role of the mass media. Studies
have pointed out the possible role of the mass media as influencing the rise
and fall of social issues in the public agenda. Whether rejected, accepted, or
modified, the comments by definers of scientific issues in news accounts have
become points of departure for personal conversations. The lay public’s
understanding of science and technology issues and its evaluation of techno-
logical risks stem more from a reliance on a broader, more popular vocabulary
of risks and benefits provided by the mass media than on the traditional risk
analysis and assessments given by experts. Risks do not just emerge as issues
for the public according to their intrinsic importance, but rather in interaction
with social processes such as the manner by which the mass media frame,
construct, or define risks. Media effects are manifested especially in issues that
lie outside the individual’s personal experience, and for which the mass media
are the only frames of reference.
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Do reports in the popular media reflect scientific discourses or lay dis-
courses? Tentative findings from my content analysis of the New York Times for
the period 1998 through 2000 show that nearly 30% of the content is devoted
to scientific discourses, in both celebratory and forensic styles. Evidently, much
of the coverage focused on social dimensions of agricultural biotechnology,
particularly on issues pertaining to control and fairness, trust and credibility,
and voluntariness. Lesser coverage was devoted to issues of tradition and
familiarity and ethics and morals.
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Q: Should scientists change their mode of address and move to a more
celebratory style when dealing with the public?
A: Some communications research is being conducted by the Environmental
Protection Agency (EPA) on the merits and demerits of using narrative
discourses over more empirical, or more forensic, discourses. But the real
challenge will be implementing the EPA findings in outreach programs or
seeing them in action through information campaigns, and that has yet to be
evaluated.
Q: Recently when I gave an introductory talk on genetically modified foods,
one of the audience members asked me the question: “If you were to be offered
only genetically modified foods for one year, would you accept it or not?” In
terms of your framework—celebratory versus forensic—as an academician,
what answer should I have given to that question?
A: As an academician, I don’t have answers to very practical questions such as
this. I think I work best as an observer. The real challenge is in evaluating
communications strategies applied in outreach and extension programs. As of
now, I have not seen any solid evaluations or findings of which strategies work
best. Suffice it to say that certainly we know that when scientists try to
celebrate, to take pride in, their own work, and to allot meaning to their
discoveries, something else happens. It is a totally different framework—one of
values and meanings—in which it is fair game for everyone to accuse you of
something else. I think the public expects the scientist simply to talk about
findings as empirically as possible, which is the reason that there is solid
recognition for the role of scientists in society. It is something else when the
scientist steps into the arena of value and meanings.
Q: Several surveys have shown that people trust in those with academic and
scientific knowledge, but they get most of their frontline information from the
media. I think it would be to the benefit of the consumer to hear from
scientists, because they do respect the empirical point of view. On the other
hand, we really do have to think about putting things into terms that the
consumer can understand and hear what the consumer is really asking,
fundamentally: is the food safe? That’s what the consumer wants to know.
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A: Albert Gunther, at the University of Wisconsin, has stated the following
in response to the strategy question of what should be said to the consumer:
when interviewed, the scientist usually begins in an empiricist mode, but then
switches to a celebratory mode, which is when the mass media interprets
and reinterprets and puts new meaning into what the scientist has said. It
is a complex communication dynamic, and I don’t think you can fault the
scientist for not answering the question—certainly the mediators of the
information from the scientist to the consumer play an important role. We
still have to come up with an examination of how the mass media tinker with
information from scientists. Who knows, rather than being actually celebratory,
added meaning may be injected by the mediator to cloud the fundamental
issue: is the food safe?
Q: The issue of celebratory science and communication is interesting. We are
seeing increasingly more of this, particularly in the genomics area in which the
identification of genes for specific diseases is leading to expectations for cures.
As funders of the scientific enterprise, we are increasingly being called upon to
be accountable. Do you see this as an increasing problem likely to erode the
public’s confidence in scientists? And do we as members of the scientific
community need to exercise control to decide what is a biologically significant
correlation—is it 20%, is it 80%? Do we need to set some thresholds for press
releases?
A: I think this is a trend. Once you start celebrating science, it is difficult to
change course. We must recognize that at some point the discourse will be
empiricist and it will eventually slide to celebratory. I think the challenge for
the scientist is, how best can you come up with communication strategies—
remember when you engage in celebratory discourse you subject yourself to
social criticism, which is an arena of public meanings, values and priorities that
you put into your communication. Whereas, with an empiricist approach, you
control the discourse. Therefore, I think that your concern about scientists
exercising more control of the information that they release, whether
celebratory or empirical, has to be seriously considered particularly by science
communicators and educators. Inasmuch as there are checks and balances in
empiricist discourse—through peer reviews and conferences—the same should
happen in celebratory discourses. And we have to be careful about whether or
not we are educating the public appropriately. If you choose to call golden rice
the “grain of hope” you open yourself up to criticism—you enter a discourse
that is not totally yours. It calls for a different way of thinking. However,
henceforth it will be impossible to concentrate on empiricist discourses; some
scientists will fight fire with fire. When Michael Jacobson asked what is the best
way to herald some of the benefits of agricultural biotechnology, he was asking
what is the best way of celebrating it.
